06:47:59 Europe / Stockholm

Attachments

Share price & Turnover

Share price change and turnover during the day of this press release

Calendar

2024-11-13 Quarterly Report 2024-Q3
2024-08-07 Quarterly Report 2024-Q2
2024-05-24 Ex-date Ordinary Dividend PHO 0.00 NOK
2024-05-23 Annual General meeting
2024-05-15 Quarterly Report 2024-Q1
2024-02-21 Year-end Report 2023
2023-11-08 Quarterly Report 2023-Q3
2023-08-09 Quarterly Report 2023-Q2
2023-05-10 Quarterly Report 2023-Q1
2023-05-04 Ex-date Ordinary Dividend PHO 0.00 NOK
2023-05-03 Annual General meeting
2023-02-24 Year-end Report 2022
2023-02-23 Year-end Report 2022
2022-11-02 Quarterly Report 2022-Q3
2022-08-10 Quarterly Report 2022-Q2
2022-05-11 Quarterly Report 2022-Q1
2022-04-29 Ex-date Ordinary Dividend PHO 0.00 NOK
2022-04-28 Annual General meeting
2022-02-23 Year-end Report 2021
2021-11-17 Quarterly Report 2021-Q3
2021-08-11 Quarterly Report 2021-Q2
2021-07-28 Extra General Meeting 2021
2021-05-21 Ex-date Ordinary Dividend PHO 0.00 NOK
2021-05-20 Annual General meeting
2021-05-19 Quarterly Report 2021-Q1
2021-03-03 Year-end Report 2020
2020-11-10 Quarterly Report 2020-Q3
2020-08-18 Quarterly Report 2020-Q2
2020-06-11 Ex-date Ordinary Dividend PHO 0.00 NOK
2020-06-10 Annual General meeting
2020-05-07 Quarterly Report 2020-Q1
2020-02-27 Year-end Report 2019
2019-11-07 Quarterly Report 2019-Q3
2019-08-07 Quarterly Report 2019-Q2
2019-06-19 Extra General Meeting 2019
2019-05-14 Quarterly Report 2019-Q1
2019-05-10 Ex-date Ordinary Dividend PHO 0.00 NOK
2019-05-09 Annual General meeting
2019-02-27 Year-end Report 2018
2018-11-08 Quarterly Report 2018-Q3
2018-08-08 Quarterly Report 2018-Q2
2018-05-23 Quarterly Report 2018-Q1
2018-05-11 Ex-date Ordinary Dividend PHO 0.00 NOK
2018-05-09 Annual General meeting
2018-02-27 Year-end Report 2017
2017-11-08 Quarterly Report 2017-Q3
2017-08-23 Quarterly Report 2017-Q2
2017-05-23 Quarterly Report 2017-Q1
2017-04-28 Ex-date Ordinary Dividend PHO 0.00 NOK
2017-04-27 Annual General meeting
2017-02-15 Year-end Report 2016
2016-11-15 Quarterly Report 2016-Q3
2016-08-23 Quarterly Report 2016-Q2
2016-05-10 Quarterly Report 2016-Q1
2016-04-29 Ex-date Ordinary Dividend PHO 0.00 NOK
2016-04-28 Annual General meeting
2016-02-11 Year-end Report 2015
2015-10-29 Quarterly Report 2015-Q3
2015-08-13 Quarterly Report 2015-Q2
2015-05-06 Quarterly Report 2015-Q1
2015-05-02 Ex-date Ordinary Dividend PHO 0.00 NOK
2015-04-30 Annual General meeting
2015-02-12 Year-end Report 2014
2014-11-06 Quarterly Report 2014-Q3
2014-08-26 Quarterly Report 2014-Q2
2014-05-28 Ex-date Ordinary Dividend PHO 0.00 NOK
2014-05-27 Annual General meeting
2014-05-07 Quarterly Report 2014-Q1
2014-02-27 Year-end Report 2013
2013-10-23 Quarterly Report 2013-Q3
2013-08-22 Quarterly Report 2013-Q2
2013-05-23 Ex-date Ordinary Dividend
2013-05-22 Annual General meeting
2013-04-25 Quarterly Report 2013-Q1
2013-02-28 Year-end Report 2012
2012-10-26 Quarterly Report 2012-Q3
2012-08-24 Quarterly Report 2012-Q2
2012-05-10 Annual General meeting
2012-04-26 Quarterly Report 2012-Q1
2012-02-16 Year-end Report 2011
2011-10-26 Quarterly Report 2011-Q3
2011-08-18 Quarterly Report 2011-Q2
2011-04-27 Quarterly Report 2011-Q1
2011-04-27 Annual General meeting
2011-02-17 Year-end Report 2010
2010-10-27 Quarterly Report 2010-Q3
2010-08-19 Quarterly Report 2010-Q2
2010-04-28 Quarterly Report 2010-Q1
2010-02-19 Year-end Report 2009
2009-11-26 Ex-date Bonus Dividend

Description

CountryNorway
ListOB Match
SectorHealth care
IndustryMedical technology
Photocure är verksamma inom medicinteknik. Bolaget specialiserar sig inom lösningar för fotodynamisk teknik. Idag används lösningarna för behandling av sjukdomar som föranlett cancer i urinblåsan och HPV. Huvudmarknaderna återfinns inom dermatologi och onkologi, där produkterna används av sjukhus och forskningsinstitut på global nivå. Bolaget grundades 1993 och har huvudkontor i Oslo, Norge.
2022-08-04 15:02:42

Oslo, Norway, 4 August 2022: Photocure ASA (Photocure, PHO: OSE) will announce the second quarter and first half year 2022 financial results on Wednesday 10 August 2022 at 08:00 CEST and invites investors, analysts and the media to a presentation at Hotel Continental, Oslo, Norway at 14:00 CEST the same day.

The investor presentation will also be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event.

The presentation is scheduled to conclude at 14:45 CEST.

The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at www.photocure.com. The streaming event is available through https://channel.royalcast.com/landingpage/hegnarmedia/20220810_2/

For further information, please contact:

Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com

Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.